Six things to know:
1. Dr. Kasarskis previously served as director of the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai. He has stepped down from that role.
2. He is, however, continuing to serve as a professor in the genetics and genomic sciences department at the Icahn School of Medicine.
3. Prior to joining Mount Sinai, he helped develop genome databases at Stanford (Calif.) University.
4. Dr. Kasarskis has also served in senior-level roles at Pacific Biosciences and Merck.
5. A biologist, he has 20 years of experience in overseeing research and technology development projects centered on software engineering, drug development and human and mouse genetics.
6. In his new role, Dr. Kasarskis will oversee data accessibility and sharing, open application development and digital asset transparency and use. He also will support entrepreneurial activities at the Icahn School of Medicine.
More articles on executive moves:
23 recent hospital, health system executive moves
Kaiser Permanente names regional chief nurse executive: 4 notes
CEO of U of Maryland Capital Region Health resigns
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
